ATE496622T1 - Verwendung von thienopyridonderivaten als ampk- aktivatoren und pharmazeutische zusammensetzungen,die diese enthalten - Google Patents
Verwendung von thienopyridonderivaten als ampk- aktivatoren und pharmazeutische zusammensetzungen,die diese enthaltenInfo
- Publication number
- ATE496622T1 ATE496622T1 AT06762350T AT06762350T ATE496622T1 AT E496622 T1 ATE496622 T1 AT E496622T1 AT 06762350 T AT06762350 T AT 06762350T AT 06762350 T AT06762350 T AT 06762350T AT E496622 T1 ATE496622 T1 AT E496622T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- containing same
- ampk activators
- thienopyridone derivatives
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 102100036009 5'-AMP-activated protein kinase catalytic subunit alpha-2 Human genes 0.000 title 1
- 101000783681 Homo sapiens 5'-AMP-activated protein kinase catalytic subunit alpha-2 Proteins 0.000 title 1
- 239000012190 activator Substances 0.000 title 1
- 208000001145 Metabolic Syndrome Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05291753A EP1754483A1 (de) | 2005-08-18 | 2005-08-18 | Verwendung von Thienopyridonederivativen als AMPK Aktivatoren und pharmazeutische Zusammensetzungen, die diese enthalten |
| PCT/EP2006/006446 WO2007019914A1 (en) | 2005-08-18 | 2006-07-03 | Use of thienopyridone derivatives as ampk activators and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE496622T1 true ATE496622T1 (de) | 2011-02-15 |
Family
ID=35636709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06762350T ATE496622T1 (de) | 2005-08-18 | 2006-07-03 | Verwendung von thienopyridonderivaten als ampk- aktivatoren und pharmazeutische zusammensetzungen,die diese enthalten |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20090105293A1 (de) |
| EP (2) | EP1754483A1 (de) |
| JP (1) | JP5161774B2 (de) |
| KR (1) | KR20080034491A (de) |
| CN (1) | CN101232883A (de) |
| AT (1) | ATE496622T1 (de) |
| AU (1) | AU2006281761B2 (de) |
| BR (1) | BRPI0614828A2 (de) |
| CA (1) | CA2619505C (de) |
| CY (1) | CY1111660T1 (de) |
| DE (1) | DE602006019880D1 (de) |
| DK (1) | DK1915150T3 (de) |
| ES (1) | ES2359860T3 (de) |
| MX (1) | MX2008002062A (de) |
| PL (1) | PL1915150T3 (de) |
| PT (1) | PT1915150E (de) |
| RU (1) | RU2416409C2 (de) |
| SI (1) | SI1915150T1 (de) |
| WO (1) | WO2007019914A1 (de) |
| ZA (1) | ZA200802454B (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005017152B4 (de) * | 2005-04-13 | 2007-02-08 | Lindauer Dornier Gmbh | Verfahren zum Trocknen von vorzugsweise plattenförmigen Produkten und Durchlauftrockner in Mehretagenbauweise |
| US8263641B2 (en) | 2007-09-10 | 2012-09-11 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| MY155836A (en) | 2008-04-11 | 2015-12-15 | Merck Patent Gmbh | Thienopyridone derivatives as amp-activated protein kinase (ampk) activators |
| JP5536757B2 (ja) | 2008-05-05 | 2014-07-02 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ａｍｐにより活性化されたプロテインキナーゼ（ａｍｐｋ）アクチベーターとしてのチエノピリドン誘導体 |
| GB0813403D0 (en) | 2008-07-22 | 2008-08-27 | Lectus Therapeutics Ltd | Potassium ion channel modulators & uses thereof |
| EP2321303B1 (de) * | 2008-08-27 | 2019-11-27 | Calcimedica, Inc. | Verbindungen als modulatoren von intrazellulärem calcium |
| US8524763B2 (en) | 2008-09-22 | 2013-09-03 | Calcimedica, Inc. | Inhibitors of store operated calcium release |
| WO2010103040A1 (en) | 2009-03-10 | 2010-09-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | 5'-adenosine monophosphate-activated protein kinase (ampk) activators for treating pulmonary hypertension |
| KR101062670B1 (ko) * | 2009-06-01 | 2011-09-06 | (주)아모레퍼시픽 | 2,5-비스-아릴-3,4-디메틸테트라하이드로퓨란 리그난을 유효성분으로 포함하는 에이엠피케이의 활성화에 의해 매개되는 비만 관련 질환의 예방 또는 치료용 조성물 |
| US8618307B2 (en) | 2009-09-16 | 2013-12-31 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| CN102666485A (zh) * | 2009-09-21 | 2012-09-12 | 霍夫曼-拉罗奇有限公司 | 烯烃羟吲哚衍生物及其用于治疗肥胖症，糖尿病和高脂血症的应用 |
| EP2552435A1 (de) | 2010-04-02 | 2013-02-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Verfahren und zusammensetzungen mit einem ampk-aktivator (metformin/troglitazon) zur behandlung von myotoner dystrophie typ 1 (dm1) |
| AU2011293201B2 (en) | 2010-08-27 | 2015-11-05 | Calcimedica Inc. | Compounds that modulate intracellular calcium |
| WO2012028582A1 (de) | 2010-09-01 | 2012-03-08 | Bayer Cropscience Ag | Herbizid wirksame ketosultame und diketopyridine |
| US9005909B2 (en) | 2011-01-06 | 2015-04-14 | Rigel Pharmaceuticals, Inc. | Whole blood assay for measuring AMPK activation |
| KR101624020B1 (ko) * | 2011-03-07 | 2016-05-24 | 글락소스미스클라인 엘엘씨 | 퀴놀리논 유도체 |
| US8889730B2 (en) | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
| EP2679591A1 (de) | 2012-06-29 | 2014-01-01 | Poxel | Thienopyridon-Derivate zur Verwendung als AMPK-Aktivatoren |
| WO2014059333A1 (en) | 2012-10-12 | 2014-04-17 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| CA2905242C (en) | 2013-03-15 | 2016-11-29 | Pfizer Inc. | Indole compounds that activate ampk |
| WO2015103480A1 (en) | 2014-01-02 | 2015-07-09 | Massachusetts Eye & Ear Infirmary | Treating ocular neovascularization |
| CN105315275B (zh) * | 2014-07-14 | 2019-10-01 | 中国科学院上海药物研究所 | 一类吡唑酮化合物及其用途 |
| US20190054096A1 (en) | 2015-09-30 | 2019-02-21 | Instituto De Medicina Molecular | Methods for attenuating parasite virulence |
| US20190350955A1 (en) | 2016-06-30 | 2019-11-21 | Inserm (Institut National De La Sante Et De La Recherche Medicale | Methods and pharmaceutical compositions for the treatment of cardiomyopathies |
| RU2766146C2 (ru) * | 2016-10-05 | 2022-02-08 | Юниверсити Оф Питтсбург - Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн | Низкомолекулярные активаторы амфк |
| WO2018156459A1 (en) * | 2017-02-22 | 2018-08-30 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Compounds and methods for inhibiting emt pathways to treat cancer, organ fibrosis and metabolic disorders |
| IL282444B2 (en) * | 2018-11-16 | 2024-07-01 | Poxel | Monohydrate potassium salt of a thienopyridone derivative and its preparation process |
| WO2020201263A1 (en) | 2019-04-01 | 2020-10-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment and prevention of cardiac remodeling |
| AU2020345766A1 (en) | 2019-09-10 | 2022-03-03 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods and materials for increasing level of phosphorylated AMPK protein |
| WO2022106892A1 (en) | 2020-11-17 | 2022-05-27 | Instituto De Medicina Molecular | Anti-malarial compounds |
| AU2022391025A1 (en) | 2021-11-19 | 2024-06-06 | The Brigham And Women's Hospital, Inc. | Bifunctional chimeric molecules for labeling of kinases with target binding moieties and methods of use thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2358150A1 (fr) * | 1976-07-13 | 1978-02-10 | Parcor | Nouvelles thieno (2,3-c) et (3,2-c) pyridines, leur procede de preparation et leur application |
| GB8625941D0 (en) * | 1986-10-30 | 1986-12-03 | Sandoz Ltd | Substituted alpha-amino acids |
| DE4444815A1 (de) * | 1994-12-15 | 1996-06-20 | Merck Patent Gmbh | Thienopyridone |
| FR2846656B1 (fr) | 2002-11-05 | 2004-12-24 | Servier Lab | Nouveaux derives d'imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US7119205B2 (en) | 2003-05-16 | 2006-10-10 | Abbott Laboratories | Thienopyridones as AMPK activators for the treatment of diabetes and obesity |
| JP2005089384A (ja) | 2003-09-18 | 2005-04-07 | Kao Corp | 持久力向上剤 |
-
2005
- 2005-08-18 EP EP05291753A patent/EP1754483A1/de not_active Withdrawn
-
2006
- 2006-07-03 RU RU2008109914/04A patent/RU2416409C2/ru active
- 2006-07-03 ES ES06762350T patent/ES2359860T3/es active Active
- 2006-07-03 DK DK06762350.4T patent/DK1915150T3/da active
- 2006-07-03 AT AT06762350T patent/ATE496622T1/de active
- 2006-07-03 DE DE602006019880T patent/DE602006019880D1/de active Active
- 2006-07-03 PL PL06762350T patent/PL1915150T3/pl unknown
- 2006-07-03 WO PCT/EP2006/006446 patent/WO2007019914A1/en not_active Ceased
- 2006-07-03 SI SI200630954T patent/SI1915150T1/sl unknown
- 2006-07-03 AU AU2006281761A patent/AU2006281761B2/en not_active Ceased
- 2006-07-03 CA CA2619505A patent/CA2619505C/en active Active
- 2006-07-03 BR BRPI0614828-0A patent/BRPI0614828A2/pt not_active IP Right Cessation
- 2006-07-03 PT PT06762350T patent/PT1915150E/pt unknown
- 2006-07-03 JP JP2008526387A patent/JP5161774B2/ja not_active Expired - Fee Related
- 2006-07-03 US US11/997,470 patent/US20090105293A1/en not_active Abandoned
- 2006-07-03 MX MX2008002062A patent/MX2008002062A/es active IP Right Grant
- 2006-07-03 EP EP06762350A patent/EP1915150B1/de active Active
- 2006-07-03 KR KR1020087005115A patent/KR20080034491A/ko not_active Ceased
- 2006-07-03 CN CNA2006800282800A patent/CN101232883A/zh active Pending
-
2008
- 2008-03-17 ZA ZA200802454A patent/ZA200802454B/xx unknown
-
2011
- 2011-03-14 CY CY20111100285T patent/CY1111660T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP5161774B2 (ja) | 2013-03-13 |
| ZA200802454B (en) | 2009-01-28 |
| ES2359860T3 (es) | 2011-05-27 |
| JP2009504693A (ja) | 2009-02-05 |
| US20090105293A1 (en) | 2009-04-23 |
| DK1915150T3 (da) | 2011-02-21 |
| RU2008109914A (ru) | 2009-09-27 |
| KR20080034491A (ko) | 2008-04-21 |
| CA2619505C (en) | 2015-04-28 |
| CN101232883A (zh) | 2008-07-30 |
| PL1915150T3 (pl) | 2011-05-31 |
| RU2416409C2 (ru) | 2011-04-20 |
| AU2006281761B2 (en) | 2012-01-19 |
| AU2006281761A1 (en) | 2007-02-22 |
| CY1111660T1 (el) | 2015-10-07 |
| BRPI0614828A2 (pt) | 2011-04-19 |
| EP1754483A1 (de) | 2007-02-21 |
| DE602006019880D1 (de) | 2011-03-10 |
| SI1915150T1 (sl) | 2011-04-29 |
| PT1915150E (pt) | 2011-05-02 |
| WO2007019914A1 (en) | 2007-02-22 |
| MX2008002062A (es) | 2008-04-16 |
| CA2619505A1 (en) | 2007-02-22 |
| EP1915150A1 (de) | 2008-04-30 |
| EP1915150B1 (de) | 2011-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE496622T1 (de) | Verwendung von thienopyridonderivaten als ampk- aktivatoren und pharmazeutische zusammensetzungen,die diese enthalten | |
| NO20091893L (no) | Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav. | |
| CY1112727T1 (el) | Παραγωγα κυκλοβουτυλ αμινης βενζοθειαζολης και η χρηση αυτων ως προσδετες των υποδοχεων ισταμινης-3 | |
| SE0401971D0 (sv) | Piperidne derivatives | |
| WO2007082808A3 (en) | Thiazoles as 11 beta-hsd1 inhibitors | |
| MX2007010532A (es) | Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii. | |
| CY1115058T1 (el) | Παραγωγα 1,2,3- τριαζολης για χρηση ως αναστολεις στεατοϋλο-coa δεσατουρασης | |
| NO20085064L (no) | 4,5-difenyl-pyrimidinyl-oksy eller -merkaptosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter | |
| DE602006009095D1 (en) | Diacylglycerol-acyltransferase-hemmer | |
| SG155961A1 (en) | Pyrazoles as 11-beta-hsd-1 | |
| NO20082445L (no) | Neuropeptid-2 reseptor-agonister | |
| NO20064288L (no) | Tetraazabenzo(E)azulen-derivater og angaloger derav | |
| ATE530519T1 (de) | Cyclobutylaminderivate | |
| ATE397605T1 (de) | Nebivolol und dessen pharmazeutisch unbedenkliche salze, herstellungsverfahren und pharmazeutische zusammensetzungen von nebivolol | |
| NO20071137L (no) | Nye piperidinderivater for behandling av depresjon | |
| SE0401970D0 (sv) | Novel compounds | |
| DE602004012758D1 (de) | Chinoxalinderivate als inhibitoren der neutrophilelastase und deren verwendung | |
| NO20085271L (no) | Muscarin reseptoragonister som er effektive i behandling av smerte, Alzheimers sykdom og schizofreni | |
| AR054347A1 (es) | Combinaciones terapeuticas para el tratamiento o la prevencion de la depresion | |
| TW200643013A (en) | Pyrazoles | |
| NO20052683L (no) | Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| UY28098A1 (es) | Derivados de anilinopirazol útiles en el tratamiento de la diabetes | |
| BRPI0417858A (pt) | composto, composição farmacêutica, e, uso de uma composição farmacêutica | |
| UY27018A1 (es) | Derivados de la pirimidina | |
| GEP20094801B (en) | Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1915150 Country of ref document: EP |